The NT-proBNP test is a blood test that measures a protein released by your heart when it’s under stress, primarily used to help diagnose or rule out heart failure. The test requires a simple blood draw with no fasting or special preparation, and the results give your doctor a window into how hard your heart is working to pump blood.
What NT-proBNP Actually Measures
Your heart muscle cells produce a hormone called proBNP, and the main trigger for its release is physical stretching of the heart wall. When blood backs up or the heart has to work harder than normal, the walls stretch, and the cells respond by making more of this hormone. As proBNP enters the bloodstream, it splits into two pieces: BNP, which is biologically active and helps regulate blood pressure and fluid balance, and NT-proBNP, an inactive fragment that lingers in the blood longer.
In a healthy heart, most of this production happens in the upper chambers (the atria). But as heart failure develops, the lower chambers (the ventricles) dramatically ramp up production. That shift is what makes NT-proBNP such a useful signal. Higher levels generally mean the heart is under greater strain. Beyond simple stretching, other factors in heart failure, like hormonal activation and low oxygen levels, further stimulate its release.
Why Your Doctor Orders This Test
The most common reason is to figure out whether symptoms like shortness of breath, fatigue, or swelling in the legs are caused by heart failure or something else entirely. Shortness of breath in particular has dozens of possible causes, from lung disease to anxiety, and NT-proBNP helps narrow the list quickly. A low result is especially useful because it makes heart failure very unlikely.
The test is also used to track how well heart failure treatment is working over time. Rising levels may signal that the condition is worsening, while falling levels suggest improvement. In some clinical settings, doctors use it as a screening tool for people at high risk of developing heart failure, even before symptoms appear. One large study found that screening at-risk patients with natriuretic peptide levels and then following up with imaging and specialist referral reduced the rate of new heart failure diagnoses.
What the Numbers Mean
The most widely cited threshold is 125 pg/mL. Below that level in a non-emergency setting, heart failure is unlikely enough that doctors can generally rule it out. The European Society of Cardiology and the universal definition of heart failure both use this cutoff. UK guidelines take a more conservative approach, using 400 pg/mL as the point above which an echocardiogram (heart ultrasound) should be ordered.
These single thresholds, however, don’t tell the whole story. NT-proBNP levels naturally rise with age and differ between men and women. In a large population study, the median level for men under 30 was just 21 pg/mL, rising to 38 pg/mL in the 50 to 59 age group and 281 pg/mL by age 80 and older. Women tend to run higher at every age: a median of 51 pg/mL under 30, 66 pg/mL in the 50 to 59 range, and 240 pg/mL at 80 and older. The upper boundary of normal (97.5th percentile) is even more dramatic, reaching nearly 6,800 pg/mL in men over 80. This is why a result that looks alarming for a 35-year-old might be perfectly normal for an 80-year-old.
NT-proBNP vs. BNP
Both BNP and NT-proBNP come from the same parent molecule and provide similar clinical information. Hospitals typically run one or the other, not both. The key practical difference is that NT-proBNP stays in the bloodstream longer, which makes it more stable and easier to measure reliably. Their absolute numbers are not interchangeable, though. An NT-proBNP of 125 pg/mL is not the same as a BNP of 125 pg/mL; each test has its own reference ranges. If you’re being monitored over time, it’s important to stick with the same test so results can be compared consistently.
Factors That Can Skew Results
Several conditions push NT-proBNP levels higher or lower in ways that don’t directly reflect heart failure severity. Understanding these is important for interpreting your results accurately.
Kidney Function
Reduced kidney function is one of the most significant confounders. NT-proBNP levels rise as kidney function declines, increasing by about 8 to 9% for every 10-unit drop in filtration rate in people with mild to moderate kidney disease, and by 23% per 10-unit drop in those with more severely impaired kidneys. This has led some to suggest using higher cutoffs for people with kidney disease, but recent evidence pushes back on that idea. Research shows that the same NT-proBNP level actually predicts a substantially higher risk of bad outcomes in people with reduced kidney function compared to those with healthy kidneys. In other words, elevated levels in someone with kidney disease should not be dismissed.
Body Weight
Higher body weight suppresses NT-proBNP levels, which can mask heart failure. In one study of patients with confirmed heart failure, using a cutoff of 900 pg/mL led to falsely normal results in about 10% of overweight patients and 15% of obese patients. Median levels dropped consistently as BMI increased. This means that in someone with a higher BMI, even a moderately elevated NT-proBNP result deserves attention.
Age and Sex
As noted above, both age and biological sex significantly affect baseline levels. Women naturally run higher than men at the same age. If population-wide screening with NT-proBNP becomes more common, age- and sex-specific thresholds will likely be necessary to avoid over-diagnosing older adults or missing heart failure in younger ones.
Non-Heart Conditions That Raise Levels
Heart failure isn’t the only thing that elevates NT-proBNP. A range of other conditions can push levels up, often because they place indirect stress on the heart. These include pulmonary embolism, pulmonary hypertension, obstructive sleep apnea, and chronic obstructive lung disease. Severe infections like sepsis can raise levels, as can stroke (both from a clot and from bleeding), severe anemia, cirrhosis, and certain toxins including some cancer chemotherapy drugs. Chronic kidney disease and uncontrolled high blood pressure are also common causes. In many of these situations, the elevation is actually mediated by real cardiac strain, even though the primary problem isn’t a heart condition.
This is why NT-proBNP is rarely interpreted in isolation. Your doctor will combine it with your symptoms, physical exam, medical history, and often an echocardiogram to reach a diagnosis.
NT-proBNP as a Predictor of Risk
Beyond diagnosis, NT-proBNP levels carry prognostic weight. In patients who have had a heart attack, higher NT-proBNP independently predicted a 44% increased risk of death after adjusting for other factors. Adding NT-proBNP to standard risk models meaningfully improved the ability to predict which patients would fare worse over five years. Interestingly, the optimal cutoff for predicting mortality dropped as BMI increased: from 5,710 pg/mL in normal-weight patients to 1,300 pg/mL in those with the highest BMI, reinforcing how much body weight influences interpretation.
What to Expect During the Test
The NT-proBNP test is a standard blood draw, typically from a vein in your arm. You don’t need to fast, stop medications, or do anything special to prepare. Results are usually available within a few hours in a hospital setting, or within a day or two if sent to an outside lab. If your doctor is using the test to monitor an existing condition, you’ll likely have it repeated at regular intervals so trends can be tracked rather than relying on a single snapshot.